abstract |
The present invention describes a composition for treating refractory cancer and/or relapsed cancer, the composition comprising an antibody molecule and an agent; and a method of treating refractory cancer and/or relapsed cancer, The method includes administering an antibody molecule and an agent. Kits including the antibody molecules and agents are also described. |